Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 46.9 TWD -0.21%
Market Cap: 4.2B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one Maxigen Biotech Inc stock under the Base Case scenario is 28.64 TWD. Compared to the current market price of 46.9 TWD, Maxigen Biotech Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
28.64 TWD
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6.7
P/S
P/S
Price to Sales
6.7
vs History
46
vs Industry
6
Median 3Y
6.7
Median 5Y
6.3
Industry
1
More Details
26.9
P/E
P/E
Price to Earnings
26.9
vs History
74
vs Industry
18
Median 3Y
29.7
Median 5Y
28.2
Industry
16.8
More Details
15.3
P/OCF
P/OCF
Price to OCF
15.3
vs History
90
vs Industry
17
Median 3Y
21.1
Median 5Y
21
Industry
11.9
More Details
16.8
P/FCFE
P/FCFE
Price to FCFE
16.8
vs History
92
vs Industry
22
Median 3Y
23.1
Median 5Y
24.7
Industry
17.6
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
42
vs Industry
18
Median 3Y
3.1
Median 5Y
2.8
Industry
1.6
More Details
5.8
EV/S
EV/S
Enterprise Value to Sales
5.8
vs History
42
vs Industry
8
Median 3Y
5.8
Median 5Y
5.2
Industry
1.2
More Details
8.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.4
vs History
63
vs Industry
16
Median 3Y
9.1
Median 5Y
8.7
Industry
3.8
More Details
20.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.7
vs History
57
vs Industry
13
Median 3Y
22.4
Median 5Y
20.5
Industry
10.3
More Details
24.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.4
vs History
73
vs Industry
14
Median 3Y
28.2
Median 5Y
26.5
Industry
12.9
More Details
13.3
EV/OCF
EV/OCF
Enterprise Value to OCF
13.3
vs History
85
vs Industry
20
Median 3Y
18
Median 5Y
18.2
Industry
12.1
More Details
14.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
14.6
vs History
88
vs Industry
22
Median 3Y
19.4
Median 5Y
20.4
Industry
15.3
More Details
3.9
EV/IC
EV/IC
Enterprise Value to IC
3.9
vs History
47
vs Industry
14
Median 3Y
3.9
Median 5Y
3.6
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Maxigen Biotech Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
Maxigen Biotech Inc
TWSE:1783
4.2B TWD 6.7 26.9 20.7 24.4
FR
L'Oreal SA
PAR:OR
181.7B EUR 4.3 28 18.7 22.2
UK
Unilever PLC
LSE:ULVR
114.1B GBP 2.3 20.8 177.5 204
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 53.1 36.5 39.8
UK
HALEON PLC
LSE:HLN
34.9B GBP 3.1 28.9 17.2 19.7
DE
Beiersdorf AG
XETRA:BEI
27.8B EUR 2.9 37.6 16 22.9
US
Estee Lauder Companies Inc
NYSE:EL
27B USD 1.7 132.8 13.1 19.9
JP
Kao Corp
TSE:4452
3T JPY 1.9 36 14.3 25.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.9 -297.8 35.4 37.8
IN
Dabur India Ltd
NSE:DABUR
903.7B INR 7.3 50.5 38.3 46.7
US
Bellring Brands Inc
NYSE:BRBR
9.9B USD 4.9 40.1 25.1 27.4
P/E Multiple
Earnings Growth P/E to Growth
TW
Maxigen Biotech Inc
TWSE:1783
Average P/E: 45.5
26.9
N/A N/A
FR
L'Oreal SA
PAR:OR
28
30%
0.9
UK
Unilever PLC
LSE:ULVR
20.8
25%
0.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
53.1
32%
1.6
UK
HALEON PLC
LSE:HLN
28.9
-7%
N/A
DE
Beiersdorf AG
XETRA:BEI
37.6
61%
0.6
US
Estee Lauder Companies Inc
NYSE:EL
132.8
245%
0.5
JP
Kao Corp
TSE:4452
36
205%
0.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
Negative Multiple: -297.8 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
50.5
39%
1.3
US
Bellring Brands Inc
NYSE:BRBR
40.1
56%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TW
Maxigen Biotech Inc
TWSE:1783
Average EV/EBITDA: 37.5
20.7
N/A N/A
FR
L'Oreal SA
PAR:OR
18.7
28%
0.7
UK
Unilever PLC
LSE:ULVR
177.5
20%
8.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.5
29%
1.2
UK
HALEON PLC
LSE:HLN
17.2
13%
1.3
DE
Beiersdorf AG
XETRA:BEI
16
11%
1.4
US
Estee Lauder Companies Inc
NYSE:EL
13.1
26%
0.5
JP
Kao Corp
TSE:4452
14.3
55%
0.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
35.4
41%
0.9
IN
Dabur India Ltd
NSE:DABUR
38.3
35%
1.1
US
Bellring Brands Inc
NYSE:BRBR
25.1
47%
0.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TW
Maxigen Biotech Inc
TWSE:1783
Average EV/EBIT: 44.6
24.4
N/A N/A
FR
L'Oreal SA
PAR:OR
22.2
34%
0.7
UK
Unilever PLC
LSE:ULVR
204
22%
9.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.8
31%
1.3
UK
HALEON PLC
LSE:HLN
19.7
13%
1.5
DE
Beiersdorf AG
XETRA:BEI
22.9
21%
1.1
US
Estee Lauder Companies Inc
NYSE:EL
19.9
35%
0.6
JP
Kao Corp
TSE:4452
25.8
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
37.8
44%
0.9
IN
Dabur India Ltd
NSE:DABUR
46.7
37%
1.3
US
Bellring Brands Inc
NYSE:BRBR
27.4
48%
0.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.